Cardiff Oncology (CRDF) Cash from Operations (2011 - 2025)

Cardiff Oncology has reported Cash from Operations for 15 years, with the latest figure at 5967000.0 in Q4 2025.

• Quarterly Cash from Operations rose 41.88% year-over-year to 5967000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 37923000.0 (down 0.61% YoY) and the FY2025 annual result came in at 37923000.0, down 0.61% from the prior year.
• Cash from Operations advanced to 5967000.0 in Q4 2025 per CRDF's latest filing, from 10834000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 4301000.0 in Q2 2021 and troughed at 12794000.0 in Q1 2025.
• A 5-year average of 8168150.0 and a median of 7848500.0 in 2023 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2021 and 2025: Cash from Operations slumped 74.39% in 2021, then soared 41.88% in 2025.
• Over 5 years, Cash from Operations stood at 7390000.0 in 2021, then decreased by 27.06% to 9390000.0 in 2022, then grew by 23.97% to 7139000.0 in 2023, then plunged by 43.82% to 10267000.0 in 2024, then jumped by 41.88% to 5967000.0 in 2025.
• According to Business Quant data, Cash from Operations over the past three periods registered 5967000.0, 10834000.0, and 8328000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.